Cyclacel Pharmaceuticals Stock Target Price and Analyst Consensus

CYCC
 Stock
  

USD 0.84  0.01  1.20%   

The current analyst and expert consensus on Cyclacel Pharmaceuticals is Strong Buy, with 4 strong buy opinions. The current projected Cyclacel Pharmaceuticals target price consensus is 20.0 with 4 analyst opinions. The most common way Cyclacel Pharmaceuticals analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Cyclacel Pharmaceuticals executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on Cyclacel Pharmaceuticals. We encourage you to use your own analysis of Cyclacel Pharmaceuticals to validate this buy or sell advice. Cyclacel Pharmaceuticals buy-or-sell recommendation module provides average expert sentiment on the projected Cyclacel Pharmaceuticals target price to derive its highest and lowest estimates based on projected price volatility of 3.559. Continue to Macroaxis Advice on Cyclacel Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
  

Cyclacel Pharmaceuticals Target Price Consensus

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Cyclacel target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts performance other than comparing it to the past results via a very sophisticated attribution analysis. Cyclacel target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
Number of Opinions4
Lowered Outlook0
Raized Outlook0
Strong Buy
Most Cyclacel analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Cyclacel stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Cyclacel Pharmaceuticals, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Cyclacel Pharmaceuticals Target Price Projection

Cyclacel Pharmaceuticals' current and average target prices are 0.84 and 20.00, respectively. The current price of Cyclacel Pharmaceuticals is the price at which Cyclacel Pharmaceuticals is currently trading. On the other hand, Cyclacel Pharmaceuticals' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Cyclacel Pharmaceuticals Market Quote on 1st of December 2022

Low Price0.81Odds
High Price0.89Odds

0.84

Target Price

Analyst Consensus On Cyclacel Pharmaceuticals Target Price

Low Estimate17.0Odds
High Estimate24.0Odds
Number of Analysts4
Standard Deviation3.559

20.0

Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Cyclacel Pharmaceuticals and the information provided on this page.

Cyclacel Pharmaceuticals Analyst Ratings

Cyclacel Pharmaceuticals' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Cyclacel Pharmaceuticals stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Cyclacel Pharmaceuticals' financials, market performance, and future outlook by experienced professionals. Cyclacel Pharmaceuticals' historical ratings below, therefore, can serve as a valuable tool for investors.

Analyst Consensus Breakdown

Average Consensus Estimates

About Cyclacel Pharmaceuticals Target Price Projections

Cyclacel Pharmaceuticals's target price is an analyst's projection of its future price. Price targets can be assigned to all types of securities, from complex investment products to stocks such as Cyclacel Pharmaceuticals and even bonds. If the target price is unavailable, it is most likely because there were not enough analyst opinions to come up with a consensus estimate. When setting a price target estimate, an analyst is trying to determine what the Stock is worth and where the price will be in a year from now. Generally, the target price of Cyclacel depends on its intrinsic valuation, beta (i.e., risk over market), and overall volatility. Most analysts publish their price targets in research reports on specific companies, along with their buy, hold, or sell recommendations. Stock price targets are often quoted in the financial news media. Macroaxis uses multiple feeds to provide overall target price projection for Cyclacel Pharmaceuticals including analysis of its current option contracts.
Cyclacel Pharmaceuticals' latest option contracts expiring on 2022-12-16 are carrying combined implied volatility of 0.0 with a put-to-call open interest ratio of 0.0 over 6 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on 2022-12-16. The current put volume is at 0, with calls trading at the volume of 1. This yields a 0.0 put-to-call volume ratio. The Cyclacel Pharmaceuticals option chain provides detailed quote and price information for the current Cyclacel Pharmaceuticals option contracts. It shows all of Cyclacel Pharmaceuticals' listed puts, calls, expiration dates, strike prices, and other pricing information.
Cyclacel Pharmaceuticals' stock options are financial instruments that give investors the right to buy or sell shares of Cyclacel Pharmaceuticals common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Cyclacel stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Cyclacel Pharmaceuticals' stock price goes up or down, the stock options follow.
Continue to Macroaxis Advice on Cyclacel Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.

Cyclacel Current Options Market Mood

Cyclacel Pharmaceuticals' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Cyclacel Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Volume

Most options investors, including buyers and sellers of Cyclacel Pharmaceuticals' calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Cyclacel Pharmaceuticals' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current Cyclacel Pharmaceuticals' option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.

Additional Cyclacel Pharmaceuticals Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Cyclacel Pharmaceuticals is a key component of Cyclacel Pharmaceuticals valuation and have some predictive power on the future returns of a Cyclacel Pharmaceuticals.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Cyclacel Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Cyclacel Pharmaceuticals in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
0.040.835.62
Details
Intrinsic
Valuation
LowReal ValueHigh
0.825.6110.40
Details
Naive
Forecast
LowNext ValueHigh
0.015540.785.56
Details
Earnings
Estimates (3)
LowProjected EPSHigh
-2.33-2.27-2.24
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Cyclacel Pharmaceuticals. Your research has to be compared to or analyzed against Cyclacel Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Cyclacel Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Cyclacel Pharmaceuticals.

Additional Cyclacel Pharmaceuticals Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Cyclacel Pharmaceuticals is a key component of Cyclacel Pharmaceuticals valuation and have some predictive power on the future returns of a Cyclacel Pharmaceuticals.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Cyclacel Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Cyclacel Pharmaceuticals in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
0.040.835.62
Details
Intrinsic
Valuation
LowReal ValueHigh
0.825.6110.40
Details
Naive
Forecast
LowNext ValueHigh
0.015540.785.56
Details
Earnings
Estimates (3)
LowProjected EPSHigh
-2.33-2.27-2.24
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Cyclacel Pharmaceuticals. Your research has to be compared to or analyzed against Cyclacel Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Cyclacel Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Cyclacel Pharmaceuticals.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Macroaxis Index
Invested few shares
Continue to Macroaxis Advice on Cyclacel Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. Note that the Cyclacel Pharmaceuticals information on this page should be used as a complementary analysis to other Cyclacel Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Complementary Tools for Cyclacel Stock analysis

When running Cyclacel Pharmaceuticals price analysis, check to measure Cyclacel Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cyclacel Pharmaceuticals is operating at the current time. Most of Cyclacel Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Cyclacel Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Cyclacel Pharmaceuticals' price. Additionally, you may evaluate how the addition of Cyclacel Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
The data published in Cyclacel Pharmaceuticals' official financial statements usually reflect Cyclacel Pharmaceuticals' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Cyclacel Pharmaceuticals. For example, before you start analyzing numbers published by Cyclacel accountants, it's critical to develop an understanding of what Cyclacel Pharmaceuticals' liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Cyclacel Pharmaceuticals' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Cyclacel Pharmaceuticals' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Cyclacel Pharmaceuticals' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Cyclacel Pharmaceuticals. Please utilize our Beneish M Score to check the likelihood of Cyclacel Pharmaceuticals' management to manipulate its earnings.